Iron is an essential element and its balance must be maintained for proper physiological functioning. Blood loss, a major cause of iron deficiency, is very common (for example, menstruating women and patients with chronic gastrointestinal (GI) blood loss) and requires diagnosis and management appropriate [1–4]. Therapeutic management of IDA mainly focuses on replenishing iron stores [1–4]. Although iron deficient people without inflammation may respond to oral iron therapy, IV iron administration is beneficial in many patient populations, including those with inflammation (for example, from kidney disease, heart failure, or rheumatic disease), patients who cannot tolerate oral iron intake, and patients who do not comply with oral iron therapy [5–8]. Even under the best of circumstances, oral iron is not well tolerated and patients are often non-adherent for a variety of reasons, including intolerable side effects and the need for multiple daily doses [9]. In addition, the often poor absorption of oral iron can contribute to a suboptimal patient response.
Young Research Forum: Journal of Blood & Lymph
Young Research Forum: Journal of Blood & Lymph
Mini Review: Journal of Blood & Lymph
Mini Review: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Opinion: Journal of Blood & Lymph
Opinion: Journal of Blood & Lymph
Editorial: Journal of Blood & Lymph
Editorial: Journal of Blood & Lymph
Review Article: Journal of Blood & Lymph
Review Article: Journal of Blood & Lymph
Editorial: Journal of Blood & Lymph
Editorial: Journal of Blood & Lymph
Review Article: Journal of Blood & Lymph
Review Article: Journal of Blood & Lymph
Posters & Accepted Abstracts: Nuclear Medicine & Radiation Therapy
Posters & Accepted Abstracts: Nuclear Medicine & Radiation Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Journal of Nephrology & Therapeutics
Scientific Tracks Abstracts: Journal of Nephrology & Therapeutics
Scientific Tracks Abstracts: Journal of Hypertension: Open Access
Scientific Tracks Abstracts: Journal of Hypertension: Open Access
Posters & Accepted Abstracts: Journal of Nephrology & Therapeutics
Posters & Accepted Abstracts: Journal of Nephrology & Therapeutics
Posters-Accepted Abstracts: Journal of Nephrology & Therapeutics
Posters-Accepted Abstracts: Journal of Nephrology & Therapeutics
Keynote Forum: Journal of Nephrology & Therapeutics
Keynote Forum: Journal of Nephrology & Therapeutics
Journal of Blood & Lymph received 443 citations as per Google Scholar report